Background: Lower gastrointestinal bleeding (LGIB), defined as bleeding occurring distal to the ligament of Treitz, is a common presenting symptom in pediatric patients. Objective: To understand the clinico-etiological pattern of LGIB in children in the age group 5-18 years. Materials and Methods: This prospective study was carried out at a tertiary health-care center in central India between January 2011 and August 2012. We consecutively enrolled all patients in the age group 5-18 years who came to our center with gross LGIB or two consecutive positive occult blood tests with at least 1-week interval between tests. All patients underwent colonoscopy (small, flexible Olympus PCF-20 colonoscope) and the findings were recorded. The procedure was done only after proper informed consent from the parents. Results: Total 38 patients were included in the study with above-mentioned inclusion and exclusion criteria, during the study period. Male to female ratio in LGIB was 2.16:1. LGIB was most common in children aged 5-10 years (63.1%), followed by 10-14 years (26.3%). Hematochezia was the most common presenting symptom (78.9%) followed by melena (21.1%). The most common causes of LGIB were colitis and colorectal polyp (31.6% each) followed by anal fissures (21.1%). Anemia was present in 68.4% patients at the time of presentation. Recurrence of LGIB was noted in 18 (47.4%) patients. Conclusion: We conclude that LGIB is most common in 5-10 years of children (school age) with hematochezia as the most common presenting symptom. Causes of LGIB in children in developing countries are same as developed countries (polyps and colitis being most common, followed by anal fissure), but further studies are required to determine the significant correlation between findings.
Background: Upper GI bleeding (UGIB) is defined as bleeding occurring proximal to ligament of treitz. Upper gastrointestinal bleeding (UGIB) can lead to potentially serious and life-threatening clinical situation in children. Globally, the cause of UGIB differs significantly depending on variations in patient population and the presence of comorbid conditions. The objective of this study was to understand the clinico-etiological pattern of upper gastrointestinal bleeding in children in the age group 5-18 years, at a tertiary care centre in central India.Methods: This prospective study was carried out at a tertiary health care centre between January 2011 and August 2012. We consecutively enrolled all patients in the age group 5-18 years who came to our centre with hematemesis or hematemesis and malena both. Blood sample for CBC, stool sample for occult blood was taken and Ultrasonography of abdomen for liver echotexture, portal vein diameter/pressure and splenomegaly, done. Then, all patients underwent upper gastro intestinal endoscopy (Olympus GIF-V70 upper GI video endoscope).Results: Total 112 patients were included in the study during the study period. UGIB is most common in the age group 5-10 years (71.4%), followed by 10-14 years (26.8%). Hematemesis is the most common presenting symptom (75%) followed by both hematemesis and melena (25%). The most common causes of UGIB on EGD were oesophageal or gastric varices (91.1%) followed by erosive gastritis (5.3%), gastric ulcer (1.8%) and esophagitis (1.8%). Most common finding on ultrasonography (USG) abdomen was extra-hepatic portal venous obstruction (EHPVO) 75%, followed by liver cirrhosis (16.1%). No abnormality was detected on USG in 8.9% of patients.Conclusions: We conclude that Upper GI bleeding is more common in 5-10 years age group with hematemesis as the main presenting symptom. The causes of upper GI bleeding in children in developing countries are different from those in developed countries (variceal bleeding due to extra hepatic portal venous obstruction is the most common cause and peptic ulcer is rare).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.